vialaudit
The Roundup

affiliate disclosure · We earn affiliate commission on some vendor links. Audits, scores, and rankings are independent — vendors do not pay for placement and do not see drafts. read more →

peptide comparison · healing & repair × metabolic

BPC-157 vs Tirzepatide

Two compounds, mechanism by mechanism. Where they overlap, where they don't, and which vendors stock each.

§ 01

Mechanism

bpc-157

BPC-157

Body Protection Compound 157

Synthetic peptide derived from a protein fragment in gastric juice. Mechanism not fully characterized; research suggests angiogenic and anti-inflammatory effects.

Full guide →
vs
tirzepatide

Tirzepatide

MounjaroZepbound

Dual GLP-1 / GIP receptor agonist. FDA-approved as Mounjaro (T2D) and Zepbound (obesity).

Full guide →
§ 02

Key facts

factBPC-157Tirzepatide
category
·healing & repairmetabolic·
half-life
·—~5 days·
research dosing
·Research literature cites 250–500 mcg daily subcutaneous for 4–8 week protocols.Research literature cites 2.5–15 mg weekly subcutaneous, escalated over 16+ weeks.·
trending
search demand
○75/10088/100●
vendors stocking
·22·
aliases
·Body Protection Compound 157Mounjaro · Zepbound·
§ 03

Use-case overlap

only bpc-157
  • tendon recovery
  • gut healing
  • soft tissue injury
both

none

only tirzepatide
  • weight loss
  • type 2 diabetes
§ 04

Where to buy

bpc-157
BPC-157
2 verified vendors
Limitless Life NootropicsParticle Peptides
See all vendors →
tirzepatide
Tirzepatide
2 verified vendors
Amino AsylumLimitless Life Nootropics
See all vendors →
§ 05

Sources

  1. [01]Pentadecapeptide BPC 157 and the central nervous system· BPC-157
  2. [02]Tirzepatide once weekly for the treatment of obesity (NEJM)· Tirzepatide
read next

Other peptide matchups

peptide matchupBPC-157 vs GHK-Cuhealing × skinpeptide matchupBPC-157 vs Retatrutidehealing × metabolicpeptide matchupBPC-157 vs Semaglutidehealing × metabolic
the roundup · monthly

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 subscribers· 0 sponsored items· 11 issues since launch